Venrock Healthcare Capital Partners III, L.P. - Significant Ownership

Signature - Title
Venrock Healthcare Capital Partners III, L.P. - By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Venrock Healthcare Capital Partners III, L.P..

Significant Ownership of Venrock Healthcare Capital Partners III, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ORKA ORUKA THERAPEUTICS, INC. Common Stock, par value $0.001 per share 11.1% $46.2M 4.15M Venrock Healthcare Capital Partners III, L.P. Feb 10, 2025
APLT KALVISTA PHARMACEUTICALS, INC. Common Stock, $0.001 par value 10.1% $2.51M 5.01M Venrock Healthcare Capital Partners III, L.P. Jan 30, 2025
ENGN enGene Holdings Inc. Common Shares 9.9% $26.7M 5.05M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
SRZN Surrozen, Inc. Common Stock, $0.0001 par value per share 9.9% $10.4M 873K Venrock Healthcare Capital Partners III, L.P. Mar 26, 2025
MRSN MERSANA THERAPEUTICS, INC. Common Stock, $0.0001 par value 8.3% $4.62M 10.3M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
FDMT 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 6.4% $12.2M 2.95M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
PRAX Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share 6.1% $45.9M 1.19M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
IPSC Century Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.7% $2.37M 3.96M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
SYRE Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.6% $49.8M 2.69M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
VRDN Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share 4.5% $57.5M 3.58M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
ATXS Astria Therapeutics, Inc. Common Stock, $0.001 par value per share 4.4% $15.3M 2.46M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
AQST Aquestive Therapeutics, Inc. Common stock, $0.001 par value per share 2.9% $7.73M 2.63M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
ADVM ADVERUM BIOTECHNOLOGIES, INC. Common Stock, $0.0001 par value 0% $0 0 Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024

Schedules 13D/G Reported by Venrock Healthcare Capital Partners III, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.